ch.oddb.org 
German | English | French
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Angiox® 250 mg:The Medicines Company (Schweiz) GmbH
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 
B01AE06 - BivalirudinATC-DDD Version 2016. Source: WHO
B - Blood and Blood Forming Organs
 
B01 - Antithrombotic Agents
 
B01A - Antithrombotic Agents
 
B01AE - Direct Thrombin Inhibitors
 

The DDD for dabigatran etexilate is based on treatment of patients with NVAF (nonvalvular atrial fibrillation).

B01AE06 - Bivalirudin
DoseRoute of administrationNote
 P 
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home